Long-Term Effectiveness, Safety, and Survival of Dupilumab in Pediatric Atopic Dermatitis.

Vroman F, Bacos-Cosma OI, Loman L, Zuithoff NPA, Kamsteeg M, van Tuyll van Serooskerken AM, van Lümig PPM, Oosting AJ, Hendriks T, de Bruin-Weller MS, Schuttelaar MA, de Graaf M

Open source

DOI: 10.1001/jamadermatol.2026.3548
Published: 2026 Sep 16
Container: JAMA dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2026.3548,
  title = {Long-Term Effectiveness, Safety, and Survival of Dupilumab in Pediatric Atopic Dermatitis.},
  author = {Vroman F and Bacos-Cosma OI and Loman L and Zuithoff NPA and Kamsteeg M and van Tuyll van Serooskerken AM and van Lümig PPM and Oosting AJ and Hendriks T and de Bruin-Weller MS and Schuttelaar MA and de Graaf M},
  year = {2026},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2026.3548},
  url = {https://doi.org/10.1001/jamadermatol.2026.3548}
}

RIS

TY  - JOUR
TI  - Long-Term Effectiveness, Safety, and Survival of Dupilumab in Pediatric Atopic Dermatitis.
AU  - Vroman F
AU  - Bacos-Cosma OI
AU  - Loman L
AU  - Zuithoff NPA
AU  - Kamsteeg M
AU  - van Tuyll van Serooskerken AM
AU  - van Lümig PPM
AU  - Oosting AJ
AU  - Hendriks T
AU  - de Bruin-Weller MS
AU  - Schuttelaar MA
AU  - de Graaf M
PY  - 2026
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2026.3548
UR  - https://doi.org/10.1001/jamadermatol.2026.3548
ER  -

APA

F, V., OI, B., L, L., NPA, Z., M, K., AM, V. T. V. S., PPM, V. L., AJ, O., T, H., MS, D. B., MA, S., & M, D. G. (2026). Long-Term Effectiveness, Safety, and Survival of Dupilumab in Pediatric Atopic Dermatitis.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2026.3548

Source records

pubmed · retrieved 2026-09-26T17:03:14.184Z